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1. Introduction 
The branched-chain 2-oxo-acid dehydrogenase 
(BCOAD) from mitochondria of several different rat 
tissues is inactivated by ATP and can be reactivated 
by incubation in Mg2’-containing buffers [l-4]. Reac- 
tivation is blocked by NaF [ 11. This activation/inacti- 
vation cycle of BCOAD also occurs in bovine and 
porcine kidney mitochondria [ 11. Work carried out on 
the system from skeletal muscle mitochondria has 
shown that inactivation requires the cleavage of the 
y-phosphate group of ATP and that modification is 
covalent. The non-metabolized ATP analog, p [NH] - 
ppA, can block the inhibitory effect of ATP when 
added prior to ATP addition, but cannot reverse the 
inhibition of the inactivated dehydrogenase [11. These 
and other data raise the possibility that BCOAD may 
be regulated by enzyme phosphorylation. This hypoth- 
esis is supported by the finding [I] that various 
procedures which separate the enzyme from its mito- 
chondrial environment (e.g., detergent treatment, 
ammonium sulfate precipitation and freeze-thawing) 
do not alter the degree of inhibition induced by ATP 
in the mitochondrial preincubation. These experiments 
suggested the feasibility of labelling the enzyme with 
32P and purifying it. 
2. Experimental 
The assay mixture consisted of: potassium phos- 
phate (pH 7.2,O.l M); MgCl2 (0.25 mM); TPP (0.2 
Abbreviations: p[NH]ppA, adenylyl 5’-[B, 7 imidoldiphos- 
phate; EGTA, ethane dioxybis (ethylamine) tetraacetate; 
DTT, dithiothreitol; PEG, polyethylene glycol; BCOAD, 
branched-chain oxo-acid dehydrogenase (EC 1.2.4.4); FCCP, 
carbonylcyanide p-trifluoromethoxyphenyl hydrazone; BSA, 
bovine serum albumin; TPP, thiamine pyrophosphate; MOPS, 
2-(Wmorpholino) propane sulfonate; PDC, pyruvate dehy- 
drogenase complex (EC 1.2.4.1 + EC 2.3.1.12 + EC 1.6.4.3) 
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mM); NAD (1 .O mM); CoASH (0.2 mM); amino- 
oxyacetate (0.2 mM); lipoic dehydrogenase (3 U/ml) 
(pig heart, Sigma). When mitochondria were to be 
assayed Triton X-l 00 (1 mg/ml) was also present. The 
reaction was initiated by addition of enzyme followed 
by addition of (4-methyl)-2-oxopentenoate (1 mM) 
or (3-methyl)-2-oxobutyrate (1 mM) and the rate of 
increase of NADH fluorescence was recorded for 12 s 
at 37’C in a Farrand Fluorometer. Freshly prepared 
NADH was used as a standard. From these data the 
initial rate was calculated as nmol/min (mu). Mito- 
chondrial protein was assayed densitometrically [S]. 
Protein in other fractions was assayed using a dye 
binding protein assay kit (BioRad Lab.). Both meth- 
ods gave equivalent measurements to the Lowry pro- 
tein assay. 
Mitochondria from -100-200 g rat kidney was 
prepared as in [6] with slight modifications. This 
procedure yielded IO-15 mg mitochondrial protein/g 
tissue. To purify BCOAD, mitochondria were diluted 
to -5 mg/ml with buffer 1: Tris-HCl(O.1 M, pH 7.8); 
sucrose (0.125 M); EGTA (2.5 mM); MgC12 (6.8 mM); 
amino-oxyacetate (0.2 mM); FCCP (0.5 PM); KC1 
(50 mM); DTT (1 mM). The mixture was incubated 
at 37°C for 20 min to maximally activate BCOAD as 
in [l] and then centrifuged for 15 min at 10 000 X g. 
The pellet was resuspended at -30 mg/ml in: potas- 
sium phosphate (20 mM, pH 6.5); TPP (0.2 mM); 
DTT (1 mM); dialyzed horse serum (1%); then was 
frozen in liquid nitrogen and thawed with tap water 
3 times. The mixture was made 0.05 M in NaCl and 
centrifuged at 15 000 X g for 30 min in a Sorvall GSA 
rotor. Sibsequent purification was a scaled down 
modification of the procedures in [7,8]. The mito- 
chondrial extract was adjusted to pH 6.4 with 5% 
acetic acid and MgC12 added to 10 mM. While stirring, 
a 50% (w/v) solution of polyethylene glycol (PEG) 
was added to 3% final cont. After stirring for an addi- 
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tional IOntin, the mixture was centrifuged at 15 000 X 
g for IO min. The precipitate was resuspended in buff- 
er 2: potassium-MOPS (50 mM, pH 7.0); TPP (0.2 
mM); MgCl? (1 mM); DTT (2 mM); horse serum (1%); 
and frozen overnight at -80°C. The follo~ng day, 
the mixture was thawed and spun at 20 000 X g for 
15 min. The pellet was resuspended in a small volume 
of the same buffer without serum and made 0.2 M in 
NaCl. The suspension was centrifuged at 20 000 X g 
for 15 min and the clear supernatant was adsorbed to 
a column of hydroxyapatite (BioRad) (0.5 X 6 cm) 
equilibrated with 10 mM potassium phosphate (pH 
7.0). The column was washed with 6 vol. 0.14 M potas- 
sium phosphate (pII 7.0). This procedure removed 
most of the protein and all of the pyruvate and 2-0x0- 
glutarate dehydrogenase activities. BCOAD was eluted 
using a gradient of potassium phosphate (pH 7.0) 
from 0.14-0.35 M. The enzyme activity eluted 0.22- 
0.28 M phosphate. 
3. Results and discussion 
As shown in table 1, BCOAD was purified 1800. 
fold over the mitochondrial pellet. If one corrects for 
the slow inactivation of BCOAD which occurs in dilute 
solutions (unpublished), the specific activity of the 
BCOAD is 9.9 U/mg (somewhat lower the bovine 
kidney enzyme which was assayed at 3O’C [8]). To 
determine whether BCOAD could be phospho~lated, 
rat kidney mitochondria were prepared as in section 2. 
After preincubation for 20 min to activate BCOAD, 
one aliquot was incubated with 0.5 mM [-Y-~‘P]ATP 
(114 ~~~rnol) in buffer 1 (contai~ng NaF (50 mM), 
oligomycin (5 pg/ml) without FCCP). Another aliquot 
was incubated in buffer without NaF or ATP. After 
20 min, mitochondria were pelleted and purified as 
Table 1 
Purification of the branched chain 2oxoacid dehydrogenase 
Fraction Protein Total act. Spec. act. Recovery 
(mg) (units) (units/ 6) 
mg) 
Mitochondria 2601 7.8 0.003 100 
Freeze-thaw 
supernatant 368 4.8 0.013 62 
PEG precipitate 14.7 3.6 0.247 46 
Buffer 2: NaCl 
supernatant 5.8 3.0 0.523 38 
Hydroxyapatite 
eluant 0.20 1.1 5.6 14 
BCOAD was purified from rat kidney mitochondria as 
described. The dehy~ogena~ was assayed using 2-oxo-3- 
methyl butyrate (1 mM) 
Table 2 
Purification of ATP-inhibited BCOAD 
Fraction -ATP +ATP Inhibition 
tmulmg) (%) 
Mitochondria 12.4 7.0 43 
Freeze-thaw supernatant 61.6 23.9 61 
PEG pellet 456.0 187.0 59 
One aliquot of rat kidney mitochondria were preincubated 
with 0.25 mM [$‘P]ATP and NaF (+ATP) and one was 
incubated without further additions (-ATP) as described. 
Each aliquot was purified separately to the PEG precipitate 
stage 
described except that 1% horse serum and NaF 
(50 mM) were present in all buffers. The fractions 
were combined, and layered on a hydroxyapatite 
column and eluted as described. Table 2 shows that 
the % inhibition of the enzyme is maintained through- 
out the purification. A substantial fraction of the 32P 
cochromatographed with BCOAD activity. This peak 
is devoid of any PDC activity. The amount of “P 
incorporated into BCOAD was 0.32 nmol/U. Values 
of 0.3-0.8 nmol/U have been obtained in 4 expt. 
Assuming spec. act. 11.8 U/mg [8], l-2.5 mol P is 
incorporated per 250 000 X g. (Mr 250 000 is the 
smallest active fraction of BCOAD observed [7].) In 
addition, this ratio is in the range of 32P incorpora- 
tion of PDC by PDC kinase (0.46 nmolfU 191). 
To verify the phosphorylation of BCOAD, the peak 
from the hydroxyapatite column was concentrated 
and electrophoresed on 1.5% agarose gel in Tris- 
acetate (50 mM, pII S.O)/DTT (0.5 mM). One lane 
was stained with Coomassie blue G250 and auto- 
radiographed. A duplicate sample was stained for 
BCOAD activity ([ 101, modified by using assay buffer 
and iodonitrotetrazolium). A densitometric scan of 
BCOAD activity (fig. 1) shows a large single peak that 
has the identical RF value as bovine BCOAD (purified 
as in [8]). PDC (gift from Dr T. E. Roche) runs more 
slowly (RF = 0.225). The autoradiograph of the same 
gel shows that a major peak of 32P runs coincident 
with BCOAD. No radioactivity appears over the region 
where PDC would be found. 
The concentrated effluent from the hydroxyapatite 
column was also subjected to SDS-polyacrylarnide 
electrophoresis. Although a number of bands are 
apparent of the stained gel (fig.2), the peaks belonging 
to BCOAD were identified by an identically run sam- 
ple of purified bovine BCOAD. (Most of the addi- 
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Fig.1. Electrophoresis of the hy~oxyapa~te peak of BCOAD 
on a 1.5% Agarose gel. The samples were run for 6 h in Tris- 
acetate (50 mM, pH I(.O)/DTT (0.5 mM). After staining and 
autoradiography A,,, was measured. Arrows indicate the 
positions of PDC (pig heart) and BCOAD (bovine kidney) 
run in parallel anes. 
tional peaks probably arise from serum protein which 
was added to the extracts during pu~~cation to pre- 
vent proteolysis [8].) An autoradiogram of the same 
gel showed one single sharp peak of 46 000 Mr corre- 
sponding to a major protein subunit of the BCOAD 
decarboxylase dimer [ 83. 
These data strongly suggest that BCOAD is phos- 
phorylated by ATI? in agreement with [3,4,11,13]. 
However, in [7,8] phosphorylation or inhibition of 
purified enzyme by ATP was not observed. These 
findings uggest that uniike PDC kinase, the kinase 
activity toward BCOAD does not copurify with 
enzyme activity. The purified BCOAD from rat is also 
not phosphorylated or inhibited by ATP (unpub- 
lished). However, i~ibition is readily observed in 
crude extracts [1,4] and these experiments indicate 
that phosphorylation ofBCOADis also observed when 
crude extracts are used. 
In summary, when rat BCOAD ii preincubated with 
[-Y-~“P] ATP and purified by hydroxyapatite chroma- 
tography, 32P is associated with the enzyme activity. ’ 
Agarose gel electrophoresis gives rise to a single peak 
of radioactivity which comigrates with the peak of 
BCOAD activity and is distinct from PDC. On SDS 
gels, a single band of radioactivity is found associated 
with the 46 OOOM, subunit of BCOAD decarboxyl- 
ase. These findings directly demonstrate hat BCOAD 
can be phosphorylated. Since it has been shown that 
BCOAD can be inactivated by ATP, it is most likely 
that inhibition of BCOAD by ATP is mediated by 
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